Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 26, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for January 8, 2007 Subscribe to this News Feed      
 

Locate a Juvederm Provider Near You Through American Health and Beauty

Select aesthetic physicians around the country are currently participating in a pre-market study on Allergan's new Anti-Wrinkle filler, Juvederm, which is becoming widely available this month, January 2007. American Health and Beauty is a national online magazine devoted to providing information and resources about aesthetic and cosmetic procedures including Juvederm, Artefill, Thermage, Fraxel, Threadlift and Rhytec Portrait.

(PRWEB) January 8, 2007 -- Select aesthetic physicians around the country are currently participating in a pre-market study on Allergan's new Anti-Wrinkle filler, Juvederm, which is becoming widely available this month, January 2007. American Health and Beauty is a national online magazine devoted to providing information and resources about aesthetic and cosmetic procedures including Juvederm, Artefill, Thermage, Fraxel, Threadlift and Rhytec Portrait.

Dermatologists and plastic surgeons who participated in the Juvederm trial study are have been testing this brand new product that promises to smooth wrinkles and last longer than similar products. Juvederm, an injectable gel, is a new anti-aging treatment that promises to give you fuller lips and smoother skin. Juvederm is already FDA approved and will be comparable in price to Restylane, which is several hundred dollars per syringe.

Early feedback on Juvederm suggests that this new hyaluronic acid dermal filler is easier to use than other hyaluronic acid fillers and may last longer than competing products like Restylane because Juvederm has a higher concentration of hylauronic acid, a substance which occurs naturally in the body and does not require skin testing.

To participate in the trial study, patients must have previously been treated with Juvederm's chief competitor, Restylane, which has been sold in the United States since 2004. Participants are asked to return to the doctor's office at three, six and nine months to evaluate results.

American Health and Beauty's doctor locator resource currently represents Juvederm providers in over 25 cities nationwide. To locate a Juvederm provider in the trial, or to locate a physician who will be offering Juvederm in January, visit American Health and Beauty.

###

Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Eva Sheie
American Health and Beauty
713-896-7457
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright